DALLAS--(BUSINESS WIRE)-- Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology ...
For small startups and academic spinoffs bringing their first molecules to market, reaching the clinic represents a major milestone. Reducing the time to investigate a new drug (IND) filing can help ...
Cambridge, MA – Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results